“Someone’s sitting in the shade today because someone planted a tree a long time ago.”
— Warren Buffett
A 20-year total return analysis can be a useful way to judge whether a business has rewarded patient shareholders through a full market cycle. In the case of Bio-Techne Corp (NASD: TECH), the long-term record shows how share price appreciation and dividend reinvestment together shaped investor outcomes over two decades.
Looking back to 2006, the key question was straightforward: if an investor had committed capital to TECH and held through market volatility, what would that investment be worth 20 years later? Based on the figures below, a $10,000 position grew to $65,378.33 by 10/02/2026, assuming all dividends were reinvested.
TECH 20-Year Return Details
| Start date: | 10/05/2006 |
|
|||
| End date: | 10/02/2026 | ||||
| Start price/share: | $13.28 | ||||
| End price/share: | $72.40 | ||||
| Starting shares: | 753.01 | ||||
| Ending shares: | 903.03 | ||||
| Dividends reinvested/share: | $5.51 | ||||
| Total return: | 553.80% | ||||
| Average annual return: | 9.84% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $65,378.33 | ||||
The result was strong by any long-term standard. Over the full 20-year period, TECH generated a 553.80% total return, which translates into an average annual return of 9.84%. In dollar terms, every $10,000 invested at the starting point grew to $65,378.33 by 10/02/2026. These figures were computed with the Dividend Channel DRIP Returns Calculator.
What Drove the 20-Year Return?
TECH’s long-run outcome reflects two sources of shareholder return:
- Share price appreciation: the stock price increased from $13.28 to $72.40.
- Dividend reinvestment: cash dividends were assumed to be reinvested into additional shares on the ex-dividend date closing price.
That reinvestment assumption matters. Starting with 753.01 shares, the position grew to 903.03 shares over the period. In other words, dividends did not merely provide income; they increased the investor’s share count, which in turn amplified the ending value as the stock price rose over time.
This is an important distinction when evaluating long-term equity performance. Price return alone can understate the full economic result, especially over extended holding periods where even modest dividends can compound meaningfully through reinvestment.
Dividend Context and Yield on Cost
Over the 20 years covered in this analysis, Bio-Techne paid a cumulative $5.51 per share in dividends, all of which were assumed to be reinvested. While TECH is not typically viewed as a high-yield stock, the dividend still contributed to total return and incremental share accumulation.
Using the most recent annualized dividend rate of $0.32 per share, the current yield calculates to approximately 0.44% based on the ending share price of $72.40. Another useful lens is yield on cost, which compares the current annual dividend to the original purchase price. On that basis, $0.32 divided by the initial $13.28 share price produces a yield on cost of about 2.41%.
Yield on cost does not measure what a new buyer earns at today’s market price, but it can help illustrate how dividend growth and a low original entry price affect the economics of a long-held position.
Key Takeaways From This TECH Investment Result
For quick reference:
- A $10,000 investment in TECH in October 2006 grew to $65,378.33 by October 2026.
- Total return was 553.80% with dividends reinvested.
- The average annual return was 9.84%.
- Share count increased from 753.01 to 903.03 through dividend reinvestment.
- TECH paid $5.51 per share in cumulative dividends over the period studied.
The broader lesson is that long-duration returns are often driven by a combination of business performance, valuation changes, and disciplined reinvestment. In TECH’s case, the historical record shows that a patient holding period produced substantial compounding despite the market volatility that inevitably occurred along the way.
“Finding the best person or the best organization to invest your money is one of the most important financial decisions you’ll ever make.” — Bill Gross
